.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
US Army
Fish and Richardson
Covington
Novartis
QuintilesIMS
Merck
Cipla
Johnson and Johnson
Queensland Health

Generated: November 25, 2017

DrugPatentWatch Database Preview

Disulfiram - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for disulfiram and what is the scope of disulfiram patent protection?

Disulfiram
is the generic ingredient in two branded drugs marketed by Mylan Pharms Inc, Sigmapharm Labs Llc, West-ward Pharms Int, Chartwell Molecules, Watson Labs, Alvogen Malta, Odyssey Pharms, Teva Womens, Watson Labs Teva, and Par Pharm, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for disulfiram. Ten suppliers are listed for this compound.

Pharmacology for disulfiram

Medical Subject Heading (MeSH) Categories for disulfiram

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Odyssey Pharms
ANTABUSE
disulfiram
TABLET;ORAL088483-001Dec 8, 1983ABRXNoYes► Subscribe► Subscribe► Subscribe
Odyssey Pharms
ANTABUSE
disulfiram
TABLET;ORAL088482-001Dec 8, 1983ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva Womens
ANTABUSE
disulfiram
TABLET;ORAL007883-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Watson Labs
DISULFIRAM
disulfiram
TABLET;ORAL086889-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
DISULFIRAM
disulfiram
TABLET;ORAL203916-001Mar 4, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Alvogen Malta
DISULFIRAM
disulfiram
TABLET;ORAL091681-001Aug 8, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Chartwell Molecules
DISULFIRAM
disulfiram
TABLET;ORAL091563-001Dec 31, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs Teva
DISULFIRAM
disulfiram
TABLET;ORAL086890-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Chartwell Molecules
DISULFIRAM
disulfiram
TABLET;ORAL091563-002Dec 31, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
DISULFIRAM
disulfiram
TABLET;ORAL202652-001Feb 5, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Federal Trade Commission
Boehringer Ingelheim
Deloitte
Mallinckrodt
Cipla
Express Scripts
Julphar
Argus Health
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot